Navigation Links
Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
Date:11/20/2008

CAMBRIDGE, Mass., Nov. 20 /PRNewswire/ -- Radius Health ("Radius") announced today that it has raised an additional $15 million to its second institutional financing round, increasing total Series C investment to $82.5 million and the total amount raised since the company's inception to $106.5 million. All existing institutional investors participated in the financing, led by MPM Bio IV NVS Strategic Fund and including MPM Capital, The Wellcome Trust, HealthCare Ventures, Oxford Bioscience Partners, BB Biotech Ventures, and Scottish Widows Investment Partnership.

Radius will use the additional funding, along with existing cash resources, to support the continued advancement of the company's clinical and preclinical development programs. Radius anticipates results from its Phase II clinical trial of BA058, a bone anabolic therapy for the treatment of osteoporosis, in the first quarter of 2009. Earlier this year, the company initiated a Phase I clinical trial of RAD1901, a novel SERM (selective estrogen receptor modulator) for the treatment of hot flashes, on which Radius expects to commence a Phase IIa study in the first quarter of 2009. In addition, the company recently announced selection of the first preclinical candidate from its SARM (selective androgen receptor modulator) discovery program for treatment of muscle loss, with an investigational new drug (IND) filing expected in the second quarter of 2009.

"We are extremely pleased with the strong continuing confidence of our investors in Radius' progress," said C. Richard Lyttle, PhD, President and CEO of Radius. "We are finishing 2008 in a strong position, with a broad and maturing portfolio of drug candidates for osteoporosis and women's health, an option agreement with a major pharmaceutical company to license BA058 for late-stage development, and significant cash resources at our disposal."

About Radius ('/>"/>

SOURCE Radius Health
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions
2. Radius Completes Enrollment of Phase II Clinical Trial of BA058 for Osteoporosis
3. Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
4. ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
5. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
6. Light Sciences Oncology Raises $40.1 Million in Series C Financing
7. Romark Laboratories Raises $18 Million in Institutional Financing
8. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
9. EntreMed Raises $20 Million to Support Clinical Development Program
10. Globus Medical Raises $110 Million in Series E Financing Round
11. AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces that a ... catalogue: North America Laparoscopes Market Outlook ... North America Laparoscopes Market Outlook to ... America Laparoscopes Market Outlook to 2020", provides key ... The report provides value, in millions of US ...
(Date:8/28/2014)... 2014 /PRNewswire-iReach/ -- CountryFocus: Healthcare, Regulatory and Reimbursement ... (Photo - http://photos.prnewswire.com/prnh/20140828/140879 ) ... Reimbursement Landscape Poland " an essential source of ... healthcare market and provides insights into the demographic, ... the report provides valuable insights into the trends ...
(Date:8/28/2014)... China , Aug. 28, 2014 ... TPI ), a pharmaceutical company that specializes in ... generics and active pharmaceutical ingredients (API) today updates ... Company,s Qionglai Facility (QLF). The ... Practice (GMP) dataset for China Food & Drug ...
Breaking Medicine Technology:North America Laparoscopes Market Outlook to 2020 2North America Laparoscopes Market Outlook to 2020 3North America Laparoscopes Market Outlook to 2020 4North America Laparoscopes Market Outlook to 2020 5North America Laparoscopes Market Outlook to 2020 6North America Laparoscopes Market Outlook to 2020 7North America Laparoscopes Market Outlook to 2020 8North America Laparoscopes Market Outlook to 2020 9North America Laparoscopes Market Outlook to 2020 10North America Laparoscopes Market Outlook to 2020 11Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2
... Reportlinker.com announces that a new market research ... Patient Self-Monitoring: Devices, Markets, Players ... http://www.reportlinker.com/p0581171/Patient-Self-Monitoring-Devices-Markets-Players-and-Prospects .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic The ... serum levels is deemed to be a ...
... A new patent covering tumor suppression technologies, including the ... awarded to The University of Texas System ... to the discovery that chromosome 3p21.3 genes act as ... also known as FUS1, the anti-cancer agent in ...
Cached Medicine Technology:Patient Self-Monitoring: Devices, Markets, Players and Prospects 2Patient Self-Monitoring: Devices, Markets, Players and Prospects 3Genprex Announces New Patent Issuance in Japan 2
(Date:8/28/2014)... Wilmington, DE (PRWEB) August 28, 2014 Blood's ... murder, gunplay, sex, money and family ties in the heart ... like no other – a story about how disrespect caused ... and limbs on many streets. , The Yayo Boyz and ... leave news reporters speechless and local onlookers in a silent ...
(Date:8/28/2014)... Arizona State University graduate student Anthony Gonzales, co-founder ... one of five finalists in Entrepreneur magazine’s 2014 College ... fourth consecutive year that an ASU student has been ... SafeSIPP, and JJ Tang, co-founder of Vantage Realized, were ... dominated the competition: Three of the five finalists were ...
(Date:8/28/2014)... -- Arguments between parents may damage their relationships with ... more than 200 families were asked to make daily ... each day, mothers and fathers rated the quality of ... On days when parents reported conflict and tension in ... strained, according to the study recently published in the ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 ABC television ... the 49th MDA Show of Strength Telethon airing Sunday, ... country to help raise funds and awareness to help ... affected by muscle disease. , Viewers tuning into the ... enjoy heart-felt appeals and introductions from some of the ...
(Date:8/28/2014)... Governor of Yucatán, Rolando Zapata Bello, presented the ... event is organized by the Microcredit Summit Campaign in ... Microenterprise Financing Program ( PRONAFIM ) and will take ... Convention Center Yucatan Siglo XXI in the city of ... to host the 17th Microcredit Summit logistically but especially ...
Breaking Medicine News(10 mins):Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 3Health News:Parents' Fights May Strain Bonds With Their Kids 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 3Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 4Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 3
... Cannabis was well-tolerated, effective when added to existing ... News) -- Medicinal marijuana helps relieve neuropathic pain ... California, San Diego, School of Medicine study. , ... that wasn,t adequately controlled by opiates or other ...
... ... PALM BEACH, Fla., Aug. 6 The Breakers Palm ... but a company,deeply committed to each employee,s personal well-being. The ... the best of Florida,s,growing season exclusively for The Breakers, 2,300 ...
... Aduromed Begins Next Step in Corporate Evolution, Restructuring the Company ... and Augmenting its Board and Management Team, ... Board: ADRM) a leading manufacturer of medical waste,treatment systems, today ... raise of $3.8 million of new equity capital. As,part of ...
... PLC Systems Inc.,(Amex: PLC ), a company focused ... financial results for the three,and six month periods ended ... were $1,310,000 compared with,$1,932,000 in the second quarter of ... was $671,000, or $0.02 per diluted share, compared to ...
... - Mylan Increases Adjusted EPS Guidance for 2008 to $0.47 ... ... MYL ),today announced its financial results for the three and six months ended,June ... the three months ended June 30,2008, which excludes the impact of certain purchase ...
... ... Second Quarter 2008 Highlights:, ... of $27.4 million, up 86.3% over second quarter 2007,- Gross margin of 25.0%, up from 21.1% in the ... in the first quarter of 2008, - Operating ...
Cached Medicine News:Health News:Medicinal Marijuana Eases Neuropathic Pain in HIV 2Health News:Luxury Resort Operates Seasonal Green Market for 2,300 Staff 2Health News:Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital 2Health News:Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital 3Health News:PLC Systems Reports Second Quarter 2008 Results 2Health News:PLC Systems Reports Second Quarter 2008 Results 3Health News:PLC Systems Reports Second Quarter 2008 Results 4Health News:PLC Systems Reports Second Quarter 2008 Results 5Health News:PLC Systems Reports Second Quarter 2008 Results 6Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 2Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 3Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 4Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 5Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 6Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 7Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 8Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 9Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 10Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 11Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 2Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 3Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 4Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 5Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 6Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 7Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 8Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 9
... Healing Shoe offers the most advanced design ... allowing patients to maintain their mobility. Thanks ... even larger portion of the forefoot is ... heads and toes to heal faster. OrthoWedge ...
The choice for inclement weather. This boot provides both closed toe and heel with a moisture resistant vinyl upper....
Ideal for use with thinner casting materials such as polyester or fiberglass. Conforms to any casting material....
This lightweight cast boot features a sturdy canvas upper. The three layer EVA rocker outsole provides excellent shock absorption....
Medicine Products: